Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Non-cash Items: 2023-2025

Historic Non-cash Items for Immunome (IMNM) over the last 3 years, with Sep 2025 value amounting to $5.0 million.

  • Immunome's Non-cash Items fell 93.11% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year decrease of 93.11%. This contributed to the annual value of $75.2 million for FY2024, which is 65.78% up from last year.
  • Latest data reveals that Immunome reported Non-cash Items of $5.0 million as of Q3 2025, which was down 92.09% from $62.9 million recorded in Q2 2025.
  • Immunome's Non-cash Items' 5-year high stood at $72.2 million during Q3 2024, with a 5-year trough of $1.4 million in Q1 2023.
  • Its 3-year average for Non-cash Items is $24.1 million, with a median of $10.3 million in 2023.
  • In the last 5 years, Immunome's Non-cash Items spiked by 544.64% in 2024 and then slumped by 93.11% in 2025.
  • Quarterly analysis of 3 years shows Immunome's Non-cash Items stood at $45.4 million in 2023, then tumbled by 92.55% to $3.4 million in 2024, then plummeted by 93.11% to $5.0 million in 2025.
  • Its last three reported values are $5.0 million in Q3 2025, $62.9 million for Q2 2025, and $3.6 million during Q1 2025.